Aura Life Sciences Private Limited
Pharmaceutical company manufacturing and trading various healthcare products and medicines.
2004 | Mumbai, Maharashtra (India) | Active
Aura Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.81 M
- Company Age 20 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.76 Cr
- Satisfied Charges ₹ 10.10 Cr
- Revenue Growth 26.72%
- Profit Growth 41.72%
- Ebitda 29.73%
- Net Worth 8.48%
- Total Assets 8.48%
About Aura Life Sciences
Aura Life Sciences Private Limited (ALSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 19 November 2004 and has a history of 20 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.81 M.
The company currently has active open charges totaling ₹9.76 Cr. The company has closed loans amounting to ₹10.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chetan Sowani and Alpana Sowani serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH2004PTC149605
- Company No.
149605
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Nov 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Aura Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chetan Sowani  | Director | 19-Nov-2004 | Current |
| Alpana Sowani | Director | 19-Nov-2004 | Current |
Financial Performance of Aura Life Sciences.
Aura Life Sciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 26.72% increase. The company also saw a substantial improvement in profitability, with a 41.72% increase in profit. The company's net worth moved up by a moderate rise of 8.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aura Life Sciences?
In 2024, Aura Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹97.60 M
Satisfied Charges
₹101.00 M
Charges Breakdown by Lending Institutions
- Others : 9.76 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Dec 2021 | Others | ₹7.60 M | Open |
| 26 Nov 2021 | Others | ₹9.00 Cr | Open |
| 23 Jun 2020 | Others | ₹8.50 M | Satisfied |
| 25 Jul 2017 | Others | ₹5.00 Cr | Satisfied |
| 27 Aug 2011 | Others | ₹3.50 Cr | Satisfied |
How Many Employees Work at Aura Life Sciences?
Unlock and access historical data on people associated with Aura Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aura Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aura Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.